Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Merit Medical Systems ( (MMSI) ) is now available.
On April 1, 2026, Merit Medical Systems acquired View Point Medical, Inc. in a merger valued at about $140 million, making View Point a wholly owned subsidiary and adding its FDA-cleared OneMark Detection Imaging System, tissue markers, and related assets to Merit’s portfolio. The deal, funded with $90 million in cash at closing and two deferred $25 million payments, broadens Merit’s leadership in wire-free, non-radioactive breast and soft tissue tumor localization, aiming to offer physicians more options at the time of biopsy and potentially reduce additional localization procedures for patients.
From the April 1, 2026 effective date through year-end 2026, the acquisition is projected to contribute $2 million to $4 million in revenue while modestly diluting non-GAAP earnings per share and GAAP net income. By 2027, View Point’s business is expected to generate $14 million to $16 million in annual revenue, grow sales of the OneMark System at least 20% per year with strong margins, and become accretive to Merit’s non-GAAP earnings per share, though GAAP earnings are projected to remain diluted until after 2027.
The most recent analyst rating on (MMSI) stock is a Buy with a $101.00 price target. To see the full list of analyst forecasts on Merit Medical Systems stock, see the MMSI Stock Forecast page.
Spark’s Take on MMSI Stock
According to Spark, TipRanks’ AI Analyst, MMSI is a Neutral.
The score is driven primarily by strong financial performance (profitability improvement and robust cash generation) and a generally positive earnings outlook despite noted headwinds. These are tempered by mixed technical momentum (below key longer-term moving averages with negative MACD) and a demanding valuation (P/E ~42 with no dividend yield provided).
To see Spark’s full report on MMSI stock, click here.
More about Merit Medical Systems
Merit Medical Systems, Inc. is a global healthcare technology company that develops, manufactures, and distributes proprietary medical devices used in interventional, diagnostic, and therapeutic procedures, with key focus areas in cardiology, radiology, oncology, critical care, and endoscopy. Founded in 1987, the company serves customers worldwide through a large sales and clinical support organization and employs approximately 7,600 people.
Average Trading Volume: 798,748
Technical Sentiment Signal: Sell
Current Market Cap: $4.1B
See more insights into MMSI stock on TipRanks’ Stock Analysis page.